Gufic Biosciences has received an approval from the National Company Law Tribunal (NCLT) for the Scheme of Merger by absorption of Gufic Stridden Bio-Pharma with the company. The Mumbai Bench of the NCLT has on September 6, 2018, pronounced the order sanctioning of the same Scheme.
Gufic Biosciences is engaged in diversified business viz. Pharma, Healthcare, Bio- Technology, Seeds, Herbal etc.